openPR Logo
Press release

WORLD SJOGREN'S DAY

07-23-2021 05:25 PM CET | Health & Medicine

Press release from: SJOGREN EUROPE

World Sjögren’s Day - July 23

Chronic fatigue is associated with reduced quality of life

Chronic fatigue is one of the most common symptoms of Sjögren's and clearly differs from the usual fatigue according to Sjögren Europe. “We describe it as an incessant, fluctuating and unreliable lack of vitality that is beyond one's control. Not everyone experiences it the same way, but fatigue is undoubtedly a permanent part of patients' lives. It is a debilitating symptom related to a reduced quality of life”, mentioned Alice Grosjean, President of Sjögren Europe.

Teri Rumpf PhD, a Sjögren’s sufferer, has identified 15 types of chronic fatigue in her recently revised article:
1. Basic or baseline fatigue is a continuous presence for many Sjogren’s sufferers.
2. Rebound fatigue is a reminder that I have done too much.
3. Sudden fatigue can hit you anywhere, at any time.
4. Forecasting changes in the weather is a side effect of Weather-related fatigue
5. Molten Lead phenomenon is a predictor of a really bad day
6. Tired-wired when you are physically exhausted but your mind is still whirling
7. Unpredictable flare-related fatigue can last for days or weeks
8. Fatigue related to other physical causes feels like climbing up a steep hill when you are walking on flat ground
9. Fatigue impairs concentration encloses me in a thick cloud of cotton wool.
10. Stress, distress, anxiety or depression create emotional fatigue that can be as exhausting as physical fatigue
11. Fatigue that comes from not sleeping well getting to sleep and staying asleep can be a challenge for Sjögren’s sufferers
12. Fatigue that comes with normal ageing it still hurts that I cannot keep up with friends of the same age
13. Fatigue that comes from a chronic illness that just won’t quit it is easy to be “sick and tired of being sick and tired” when Sjogren’s just does not go away
14. Fatigue that comes from trying to keep up with family and friends who don’t have a chronic illness my body won’t co-operate and I can’t keep up
15. Doctor fatigue repeated clinical visits and tests are exhausting

"Sjögren Europe want to contribute to increasing awareness and recognition of fatigue as a major factor in Sjögren's and promote understanding that Sjögren's is a systemic disease. To mark World Sjögren’s Day, Sjögren Europe and its members – the national patient associations, have posted the 15 types of chronic fatigue on social media. With this, we hope to highlight an issue that is often misinterpreted and treated so badly”, said Alice Grosjean.

Sjogren's affects the whole body. Many patients experience dry eye, dry mouth, joint pain and fatigue. However, the disease can also cause other serious complications such as chronic pain, organ dysfunction, neuropathy and lymphoma. Women are nine times more likely to develop Sjogren’s than men and the diagnosis usually occurs around the age of 40.

The etiology of the disease is unknown. Genetic and environmental factors, such as relatively common viral infections, appear to play a role in its onset. The disease is caused by the production of antibodies, and immune cells that attack the connective tissue, that of the exocrine glands especially, such as the lacrimal and salivary glands. This results in long-term inflammation of these glands leading to dysfunction, destruction, and a reduction in the production of saliva and/or tears, as well as by the swelling -sometimes- of the salivary glands.
###

About Sjögren Europe
Sjögren Europe, a federation of national associations representing patients with Sjögren, was founded in Switzerland in 2019. All members of the Board - except one, have Sjögren's. The members of the Board are all volunteers and there is no paid staff. The Scientific Committee of the Federation consists of renowned medical specialists in Sjögren’s Syndrome.
The main objectives of Sjögren Europe are:
• The strengthening of national patient associations
• Updating and increasing the knowledge and awareness of all (patients, caregivers, medical community, governmental agencies, health professionals, pharmaceutical companies and the general public)
• The achievement of an optimal care system, psychosocial support and quality of life for all patients with Sjögren’s in Europe
• Involvement of patients in decisions, programs, strategies, etc. that affect patients with Sjögren’s in Europe
• The collaboration, participation, and involvement of patients in clinical trials but also the implementation of research and research projects related to the disease and the publication of their results
• Sjögren Europe is member of EURORDIS and a supporting member of EULAR PARE.

On World Sjögren’s Day- July 23
World Sjögren’s Day was created to honour the birthday of Dr Henrik Sjögren, the Swedish ophthalmologist who discovered the disease in 1933.
World Sjögren’s Day aimed to put a face to the millions of people living with this disease or suffer from symptoms and have not been diagnosed and aims to raise awareness for Sjögren’s, while stressing the need for further research, quicker diagnostics and new treatments. This day, patients, their families, and friends come together around the world to make their voices heard.

Sjögren Europe
do Alice Grosjean
Rue du Marche-Neuf 2 7 2 503 Biel/Bienne
Press Contact: Katy Antonopoulou

Sjögren Europe, a federation of national associations representing patients with Sjögren, was founded in Switzerland in 2019. All members of the Board - except one, have Sjögren's. The members of the Board are all volunteers and there is no paid staff. The Scientific Committee of the Federation consists of renowned medical specialists in Sjögren’s Syndrome.
The main objectives of Sjögren Europe are:
• The strengthening of national patient associations
• Updating and increasing the knowledge and awareness of all (patients, caregivers, medical community, governmental agencies, health professionals, pharmaceutical companies and the general public)
• The achievement of an optimal care system, psychosocial support and quality of life for all patients with Sjögren’s in Europe
• Involvement of patients in decisions, programs, strategies, etc. that affect patients with Sjögren’s in Europe
• The collaboration, participation, and involvement of patients in clinical trials but also the implementation of research and research projects related to the disease and the publication of their results
• Sjögren Europe is member of EURORDIS and a supporting member of EULAR PARE.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release WORLD SJOGREN'S DAY here

News-ID: 2335977 • Views:

More Releases for Sjögren

Demand for Autoimmune Disease Diagnostic Products Remains High in North America
Around 3% of the people in the U.S. are affected by autoimmune diseases every year, according to Johns Hopkins University. In such diseases, the immune system malfunctions and starts attacking the healthy cells instead of pathogens. Some of the common autoimmune diseases are celiac disease, lupus, myasthenia gravis, rheumatoid arthritis, Grave’s disease, type 1 diabetes, Guillain–Barre syndrome, multiple sclerosis, and Sjögren syndrome. These diseases are often not treatable, therefore have
Evans Syndrome Market Key Players 2019 - Merck & Co., Sanofi, Astellas Pharma, I …
Market Research Future (MRFR) has announced a new release on the global Evans Syndrome market. The report takes into account the global Evans Syndrome market’s historical growth trajectory and major growth drivers and restraints in order to come up with a reliable projection for the market’s likely growth trajectory over the forecast period from 2018 to 2023. Market Synopsis of the Global Evans Syndrome Market Evans syndrome (ES), is an autoimmune disorder
Evans Syndrome Market Growth Boosting Strategies By Top Manufacturers like Pfize …
This report studies the Global Evans Syndrome Market status and outlook of Global Market 2018. The report begins with the overview of Industry Chain structure, and describes industry environment, then analyses market size and... Evans syndrome (ES), is an autoimmune disorder characterized by the subsequent or simultaneous development of autoimmune hemolytic anemia, and immune thrombocytopenia. It is classified as primary or secondary based on its association with others diseases, such as
Evans Syndrome Market Expected to show Enthralling Growth of 10.2% CAGR by 2023 …
Market Synopsis of the Global Evans Syndrome Market Evans syndrome (ES), is an autoimmune disorder characterized by the subsequent or simultaneous development of autoimmune hemolytic anemia, and immune thrombocytopenia. It is classified as primary or secondary based on its association with others diseases, such as primary antiphospholipid syndrome, systemic lupus erythematous (SLE), Sjögren syndrome, Hodgkin lymphoma, IgA deficiency, and chronic lymphocytic leukemia. Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5136 According to the Centers for Disease
Evans Syndrome: Projection of Each Major Segment, Drugs and Treatment over the F …
Market Scenario Evans syndrome (ES), is an autoimmune disorder characterized by the subsequent or simultaneous development of autoimmune hemolytic anemia, and immune thrombocytopenia. It is classified as primary or secondary based on its association with others diseases, such as primary antiphospholipid syndrome, systemic lupus erythematous (SLE), Sjögren syndrome, Hodgkin lymphoma, IgA deficiency, and chronic lymphocytic leukemia. According to the Centers for Disease Control & Prevention, autoimmune disorder is the third most common
Leading Peptides expert to discuss Liquid Chromatography and Mass Spetrometry in …
Jörgen Kjellgren Sjögren, Senior Research Scientist at Ferring Pharmaceuticals, has joined the expert speaker lineup for SMi Group’s 4th Peptides Event in July. With over 15 years of expertise in peptides, Jörgen will bring insights into using Liquid Chromatography and Mass Spetrometry as a key technique to understanding the fate of impurities using examples from Ferring's synthetic therapeutic peptide portfolio. In the lead to the event, the SMi Group spoke to